Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kengo Azushima

Showing results (51-60 of 109) with videos related to

Pageof 11
Sort By:
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|June 12, 2020
Low-density-lipoprotein apheresis-mediated endothelial activation therapy to severe-peripheral artery disease study: Rationale and study designEiko Ueda, Yoshiyuki Toya, Hiromichi Wakui, et al.
Scientific Reports|December 9, 2021
Effects of tumor necrosis factor-α inhibition on kidney fibrosis and inflammation in a mouse model of aristolochic acid nephropathyShinya Taguchi, Kengo Azushima, Takahiro Yamaji, et al.
Lipids in Health and Disease|December 10, 2015
Effects of pitavastatin add-on therapy on chronic kidney disease with albuminuria and dyslipidemiaMasato Ohsawa, Kouichi Tamura, Hiromichi Wakui, et al.
Clinical Nephrology|September 2, 2020
Effect of renin-angiotensin system blockers on contrast-induced acute kidney injury in patients with normal or mild-to-moderate reduced kidney function undergoing coronary angiography: A systematic review and meta-analysisTakayuki Yamada, Tomohiro Fujisaki, Nitin Chopra, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|December 31, 2024
Proteomic serum profiles before and after lipoprotein apheresis in patients with peripheral artery disease with ulcerationKohei Ishiga, Tatsuki Uehara, Hiromichi Wakui, et al.
Scientific Reports|January 8, 2025
Leucine-rich alpha-2-glycoprotein 1 deficiency suppresses ischemia-reperfusion injury-induced renal fibrosisNaohito Okami, Hiromichi Wakui, Kengo Azushima, et al.
Scientific Reports|April 19, 2019
Effects of rikkunshito on renal fibrosis and inflammation in angiotensin II-infused miceKengo Azushima, Kazushi Uneda, Hiromichi Wakui, et al.
International Journal of Molecular Sciences|August 21, 2013
L/N-type calcium channel blocker cilnidipine added to renin-angiotensin inhibition improves ambulatory blood pressure profile and suppresses cardiac hypertrophy in hypertension with chronic kidney diseaseTomohiko Kanaoka, Kouichi Tamura, Hiromichi Wakui, et al.
International Journal of Molecular Sciences|July 27, 2013
Addition of aliskiren to Angiotensin receptor blocker improves ambulatory blood pressure profile and cardiorenal function better than addition of benazepril in chronic kidney diseaseMasato Ohsawa, Kouichi Tamura, Tomohiko Kanaoka, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|November 13, 2023
Angiotensin II type 1 receptor-associated protein deletion combined with angiotensin II stimulation accelerates the development of diabetic kidney disease in mice on a C57BL/6 strainShinya Taguchi, Kengo Azushima, Takahiro Yamaji, et al.
Pageof 11

Showing results (51-60 of 109) with videos related to

Sort By:
Pageof 11
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|June 12, 2020
Low-density-lipoprotein apheresis-mediated endothelial activation therapy to severe-peripheral artery disease study: Rationale and study designEiko Ueda, Yoshiyuki Toya, Hiromichi Wakui, et al.
Scientific Reports|December 9, 2021
Effects of tumor necrosis factor-α inhibition on kidney fibrosis and inflammation in a mouse model of aristolochic acid nephropathyShinya Taguchi, Kengo Azushima, Takahiro Yamaji, et al.
Lipids in Health and Disease|December 10, 2015
Effects of pitavastatin add-on therapy on chronic kidney disease with albuminuria and dyslipidemiaMasato Ohsawa, Kouichi Tamura, Hiromichi Wakui, et al.
Clinical Nephrology|September 2, 2020
Effect of renin-angiotensin system blockers on contrast-induced acute kidney injury in patients with normal or mild-to-moderate reduced kidney function undergoing coronary angiography: A systematic review and meta-analysisTakayuki Yamada, Tomohiro Fujisaki, Nitin Chopra, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|December 31, 2024
Proteomic serum profiles before and after lipoprotein apheresis in patients with peripheral artery disease with ulcerationKohei Ishiga, Tatsuki Uehara, Hiromichi Wakui, et al.
Scientific Reports|January 8, 2025
Leucine-rich alpha-2-glycoprotein 1 deficiency suppresses ischemia-reperfusion injury-induced renal fibrosisNaohito Okami, Hiromichi Wakui, Kengo Azushima, et al.
Scientific Reports|April 19, 2019
Effects of rikkunshito on renal fibrosis and inflammation in angiotensin II-infused miceKengo Azushima, Kazushi Uneda, Hiromichi Wakui, et al.
International Journal of Molecular Sciences|August 21, 2013
L/N-type calcium channel blocker cilnidipine added to renin-angiotensin inhibition improves ambulatory blood pressure profile and suppresses cardiac hypertrophy in hypertension with chronic kidney diseaseTomohiko Kanaoka, Kouichi Tamura, Hiromichi Wakui, et al.
International Journal of Molecular Sciences|July 27, 2013
Addition of aliskiren to Angiotensin receptor blocker improves ambulatory blood pressure profile and cardiorenal function better than addition of benazepril in chronic kidney diseaseMasato Ohsawa, Kouichi Tamura, Tomohiko Kanaoka, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|November 13, 2023
Angiotensin II type 1 receptor-associated protein deletion combined with angiotensin II stimulation accelerates the development of diabetic kidney disease in mice on a C57BL/6 strainShinya Taguchi, Kengo Azushima, Takahiro Yamaji, et al.
Pageof 11